ARCHIVES

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

This article is from The Cancer Letter archive.

Vol. 27 No. 16 | April 20, 2001

Download PDF Visit The Full Archive

Related Articles

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

NCI Programs: New RAID Program Offers NCI Expertise In Drug Development

April 24, 1998

DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs

December 4, 1992

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

Hawaii Epidemiology Studies Offer Opportunities For Major Impact On Cancer Incidence, Survival

January 4, 1985

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011